Annexon (ANNX) Income towards Parent Company (2019 - 2026)

Annexon's (ANNX) quarterly Income towards Parent Company came in at -$78.1 million in Q1 2026, down 9.25% year-on-year from -$86.0 million in Q1 2025, and down 15.75% quarter-over-quarter from -$67.4 million in Q4 2025.

Annexon (ANNX) Income towards Parent Company (2019 - 2026) Analysis & Trends

Annexon's Income towards Parent Company history runs 8 years deep, the most recent figure standing at -$78.1 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 9.25% year-over-year to -$78.1 million in Q1 2026; TTM through Mar 2026 was -$268.0 million, a 4.7% increase from a year earlier, with the FY2025 full-year figure at -$441.3 million, down 31.76% from the prior year.
  • Income towards Parent Company eased to -$78.1 million in Q1 2026 per ANNX's latest filing, from -$67.4 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$40.0 million in Q4 2022 and bottomed at -$160.9 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$71.5 million (2025), against an average of -$74.2 million.
  • Across the five-year window, Income towards Parent Company slumped 302.25% in 2023 and jumped 64.82% in 2024, its largest moves.
  • Year by year, Income towards Parent Company stood at -$40.0 million in 2022, then slumped by 302.25% to -$160.9 million in 2023, then soared by 64.82% to -$56.6 million in 2024, then retreated by 19.16% to -$67.4 million in 2025, then decreased by 15.75% to -$78.1 million in 2026.
  • Per Business Quant, the three latest ANNX Income towards Parent Company figures stand at -$78.1 million (Q1 2026), -$67.4 million (Q4 2025), and -$62.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Annexon 1.02 Bn 798.41 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -78.07 Mn
Dec 31, 2025 -67.45 Mn
Sep 30, 2025 -62.62 Mn
Jun 30, 2025 -59.91 Mn
Mar 31, 2025 -71.46 Mn
Dec 31, 2024 -56.60 Mn
Sep 30, 2024 -78.85 Mn
Jun 30, 2024 -74.36 Mn
Mar 31, 2024 -70.62 Mn
Dec 31, 2023 -160.89 Mn
Sep 30, 2023 -78.77 Mn
Jun 30, 2023 -82.85 Mn
Mar 31, 2023 -54.96 Mn
Dec 31, 2022 -40.00 Mn
Sep 30, 2022 -84.77 Mn
Jun 30, 2022 -53.21 Mn
Mar 31, 2022 -86.25 Mn
Dec 31, 2021 -47.75 Mn
Sep 30, 2021 -35.60 Mn
Jun 30, 2021 -31.29 Mn